APO got the print it needed on June 8 — the stock jumped roughly 3.6% on results day and has added 3% across the week to close at $132.70 — but the options market has quietly shifted tone now that the catalyst has passed.
The most notable post-earnings development is in the options positioning. Call demand drove the put/call ratio to a one-year low of 0.83 heading into the June 8 print; after the release, the PCR has bounced back to 0.84 but that alone understates the shift — the z-score, which was -3.45 going into results, has now compressed sharply toward its 20-day mean of 0.876. The options market was right to lean bullish on the print, but the excess call positioning that made the pre-earnings setup so striking has unwound almost entirely. What was a rare skew is now close to neutral.
Short positioning has continued its gradual retreat and the borrow market remains relaxed. Short interest has eased to 5.17% of the free float, down 3.4% on the week and 5.6% over the past month — the steady unwind that was underway before the print has continued through it. Availability is running at 240%, meaning roughly two-and-a-half shares remain available to lend for every one currently borrowed, comfortably within the normal range and well above the 52-week tightest level of 202%. Cost to borrow sits at a modest 0.51%, drifting slightly lower on the week. There is nothing in the lending market that suggests pressure from either direction — the short base is shrinking, borrows are easy, and the overall setup reads as unhurried.
The Street broadly validated the bull case that drove pre-earnings call demand. The consensus mean target is $150.25 against a current price of $132.70 — roughly 13% upside remaining. Analyst moves since the print have been constructive: Piper Sandler raised its target to $157 from $146 on May 26, maintaining Overweight, while UBS lifted to $158 from $138 with a Buy. The bears' worry — that 2025 SRE growth would disappoint, falling from ~9.5% expectations to mid-single digits — found partial expression in the post-earnings dip back in May, but the June 8 result has partially addressed it. Morgan Stanley's target at $165 remains the high anchor, while Barclays at $131 sits fractionally below the current price, making it effectively the lone hold among the recent movers. Valuation multiples have drifted modestly higher over the past month; price-to-book has expanded by roughly 0.28x over thirty days to 3.09x, and the earnings yield factor score has slipped — the stock is slightly less cheap than it was.
Insider activity adds a note of caution to the bullish read. The subsidiary president John Zito sold just over 48,600 shares across three transactions on May 27 at prices around $130–$132, netting roughly $6.4 million. CFO Martin Kelly sold a further 7,000 shares on May 14 at $134.64. Neither trade is alarming in scale — the significance scores are modest — but the net direction over the past 90 days is entirely one-sided: roughly $7.3 million in net selling, no purchases. Co-founder Marc Rowan trimmed 140,000 shares in a recent period and the founder cohort — Leon Black and Joshua Harris — hold large legacy positions but show no recent buying activity. With the stock now at $132.70, several of these insider sales were executed at or near current levels, which is at minimum a reason to note that those closest to the business are not adding.
Capital Research and Management added nearly 10 million shares in their most recent filing, bringing their stake to 9.6% — the largest active manager position and a meaningful vote of confidence. That institutional accumulation runs directly counter to the insider-selling trend and reflects the divergence that has defined APO's setup for much of the year: large external holders building while internal sellers trim. The next earnings event is scheduled for July 31, giving the stock a full seven weeks for the post-print positioning reset to play out — and the degree to which the PCR normalises or the call skew rebuilds from here will be the clearest read on whether the June print genuinely satisfied the bulls.
See the live data behind this article on ORTEX.
Open APO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
